paraoxon has been researched along with phenylacetic acid in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 10 (38.46) | 18.2507 |
| 2000's | 8 (30.77) | 29.6817 |
| 2010's | 7 (26.92) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobashi, K; Takebe, S; Watanabe, M | 1 |
| Geldmacher-von Mallinckrodt, M; Haas, A | 1 |
| Hardy, AR; Mackness, MI; Thompson, HM; Walker, CH | 1 |
| Blain, PG; McCracken, NW; Williams, FM | 2 |
| Pavković, E; Simeon, V | 1 |
| Pavković, E; Radić, Z; Reiner, E; Simeon, V | 1 |
| Charmes, JP; Dantoine, TF; Debord, J; Lachatre, G; Leroux-Robert, C; Marquet, P; Merle, L | 1 |
| Gil, F; Hernández, AF; Pla, A; Rodrigo, L | 1 |
| Chemnitius, JM; Nebendahl, K; Severin, RM; Zech, R | 1 |
| Gavella, M; Lipovac, V; Mrzljak, V; Reiner, E; Simeon-Rudolf, V; Svedruzic, D | 1 |
| Cherry, N; Dippnall, M; Durrington, P; Mackness, B; Mackness, M; Povey, A; Smith, T; Thomson, S | 1 |
| Graessler, J; Kopprasch, S; Kuhlisch, E; Pietzsch, J | 1 |
| Akhtar, M; Allemann, RK; Bargota, RS; Biggadike, K; Gani, D | 1 |
| Bełtowski, J; Jamroz, A; Wójcicka, G | 1 |
| Koanantakul, B; Mackness, B; Mackness, MI; Phuntuwate, W; Suthisisang, C | 1 |
| Dirican, M; Sarandöl, E; Taş, S | 1 |
| Ackermann, C; Fate, G; Jewell, C; Payne, NA; Voorman, R; Williams, FM | 1 |
| Bartosik-Psujek, H; Beltowski, J; Jamroz-Wisniewska, A; Stelmasiak, Z | 1 |
| Aerts, P; Coman, A; Lixandru, D; Manuel-Y-Keenoy, B; Mohora, M; Stoian, I; van Gils, C | 1 |
| Baker, AM; Boggess, K; Haeri, S; Klein, RL | 1 |
| Gill, KD; Gupta, N; Maturu, VN; Sharma, YP; Singh, S | 1 |
| Bard, JM; Bobin-Dubigeon, C; Campone, M; Classe, JM; Hervé, M; Jaffré, I; Joalland, MP | 1 |
| Čepelak, I; Grubišić, TŽ; Kopčinović, LM; Pancirov, D; Rajković, MG; Rumora, L | 1 |
| Abam, EO; Ademuyiwa, O; Afolabi, OK; Babayemi, DO; Balogun, EA; Dosumu, OA; Odukoya, OO; Ogunrinola, OO; Onunkwor, OB; Wusu, AD | 1 |
| Bełtowski, J; Pastryk, JE; Rusek, M | 1 |
26 other study(ies) available for paraoxon and phenylacetic acid
| Article | Year |
|---|---|
High paraoxon-hydrolyzing activity in organophosphorus insecticide-resistant mosquitoes.
Topics: Animals; Anopheles; Chromatography, Thin Layer; Culex; Culicidae; Fenitrothion; Hydrolysis; Insecticide Resistance; Insecticides; Paraoxon; Phenylacetates | 1991 |
Enzyme visualization with partially dehydrated agarose substrate layers: detection of paraoxonase after thin-layer isoelectric focusing in agarose.
Topics: Aryldialkylphosphatase; Humans; Hydrolysis; Isoelectric Focusing; Isoenzymes; Naphthols; Paraoxon; Phenylacetates; Phosphoric Monoester Hydrolases; Polymorphism, Genetic; Sensitivity and Specificity; Sepharose; Serum Albumin | 1990 |
Distinction between 'A'-esterases and arylesterases. Implications for esterase classification.
Topics: Animals; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Chromatography, Gel; Humans; Paraoxon; Phenylacetates; Phosphoric Monoester Hydrolases; Species Specificity; Substrate Specificity | 1987 |
Peripheral esterases in the rat: effects of classical inducers.
Topics: Animals; Benzoflavones; beta-Naphthoflavone; Clofibric Acid; Enzyme Induction; Esterases; Herbicides; Hydrolysis; Inactivation, Metabolic; Liver; Lung; Male; Paraoxon; Phenobarbital; Phenylacetates; Pyridines; Rats; Rats, Wistar; Skin | 1993 |
Heat inactivation of paraoxonase and arylesterase activities in human and rabbit serum.
Topics: Animals; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Drug Interactions; Enzyme Activation; Enzyme Stability; Hot Temperature; Humans; Hydrolysis; Kinetics; Naphthaleneacetic Acids; Paraoxon; Phenylacetates; Phosphoric Monoester Hydrolases; Rabbits | 1993 |
Differentiation of esterases reacting with organophosphorus compounds.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aryldialkylphosphatase; Cholinesterase Inhibitors; Cholinesterases; Edetic Acid; Esterases; Female; Humans; Hydrolysis; Kinetics; Male; Middle Aged; Naphthaleneacetic Acids; Nitrophenols; Organophosphates; Organophosphorus Compounds; Paraoxon; Phenylacetates; Phosphoric Monoester Hydrolases; Physostigmine; Sensitivity and Specificity; Substrate Specificity; Tetraisopropylpyrophosphamide; Thiocholine | 1993 |
Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood.
Topics: Animals; Carbaryl; Cytosol; Erythrocytes; Esterases; Inactivation, Metabolic; Kinetics; Liver; Male; Microsomes; Paraoxon; Phenylacetates; Pyridines; Rats; Rats, Wistar; Skin; Xenobiotics | 1993 |
Decrease of serum paraoxonase activity in chronic renal failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Aryldialkylphosphatase; Esterases; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Nitrophenols; Paraoxon; Peritoneal Dialysis; Phenylacetates; Reference Values; Renal Dialysis | 1998 |
Identification of two rat liver proteins with paraoxonase activity: biochemical evidence for the identity of paraoxonase and arylesterase.
Topics: Animals; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Esterases; Glycolates; Hydrogen-Ion Concentration; Isoenzymes; Male; Metals; Mice; Microsomes, Liver; Paraoxon; Phenylacetates; Rats; Rats, Wistar; Substrate Specificity | 1999 |
Paraoxonase polymorphism in rabbits.
Topics: Animals; Aryldialkylphosphatase; Carboxylesterase; Carboxylic Ester Hydrolases; Cattle; Esterases; Female; Humans; Hydrolysis; Isoenzymes; Kinetics; Liver; Male; Paraoxon; Phenylacetates; Polymorphism, Genetic; Rabbits | 1999 |
Paraoxonase and arylesterase activities in the serum of two hyperlipoproteinaemic patients after repeated extracorporal lipid precipitation.
Topics: Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Chelating Agents; Chemical Precipitation; Diabetes Mellitus, Type 2; Edetic Acid; Esterases; Extracorporeal Circulation; Heparin; Humans; Hyperlipoproteinemias; Lipids; Paraoxon; Phenylacetates; Renal Dialysis; Substrate Specificity | 1999 |
Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep.
Topics: Animals; Aryldialkylphosphatase; Biomarkers; Case-Control Studies; Esterases; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Insecticides; Liver; Liver Function Tests; Male; Middle Aged; Occupational Diseases; Organophosphate Poisoning; Organophosphorus Compounds; Paraoxon; Phenylacetates; Polymorphism, Genetic; Risk Factors; Sheep | 2003 |
Lack of association between serum paraoxonase 1 activities and increased oxidized low-density lipoprotein levels in impaired glucose tolerance and newly diagnosed diabetes mellitus.
Topics: Adult; Aged; Aryldialkylphosphatase; C-Peptide; Diabetes Mellitus, Type 2; Esterases; Female; Glucose Intolerance; Glycated Hemoglobin; Homeostasis; Humans; Insulin; Lipoproteins, LDL; Male; Middle Aged; Paraoxon; Phenotype; Phenylacetates; Substrate Specificity | 2003 |
Structure-activity relationship on human serum paraoxonase (PON1) using substrate analogues and inhibitors.
Topics: Aryldialkylphosphatase; Binding Sites; Humans; Hydrolysis; Inhibitory Concentration 50; Kinetics; Paraoxon; Phenylacetates; Structure-Activity Relationship; Substrate Specificity | 2003 |
Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Antimetabolites, Antineoplastic; Antioxidants; Aryldialkylphosphatase; Biomarkers; Cholinesterase Inhibitors; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperlipidemias; Isoprostanes; Lactones; Leptin; Male; Models, Cardiovascular; Oxidative Stress; Paraoxon; Phenylacetates; Rats; Rats, Wistar; Statistics as Topic | 2003 |
Paraoxonase 1 status in the Thai population.
Topics: Adult; Analysis of Variance; Apolipoproteins; Aryldialkylphosphatase; Female; Gene Frequency; Humans; Linkage Disequilibrium; Lipids; Lipoproteins; Male; Middle Aged; Organophosphorus Compounds; Paraoxon; Phenylacetates; Polymorphism, Genetic; Thailand | 2005 |
High-dose taurine supplementation increases serum paraoxonase and arylesterase activities in experimental hypothyroidism.
Topics: Animals; Antioxidants; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Cholesterol; Cholesterol, HDL; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Hypothyroidism; Lipid Peroxidation; Male; Malondialdehyde; Paraoxon; Phenylacetates; Propylthiouracil; Rats; Rats, Sprague-Dawley; Taurine; Triglycerides; Up-Regulation | 2007 |
Specificity of procaine and ester hydrolysis by human, minipig, and rat skin and liver.
Topics: Animals; Enzyme Inhibitors; Esterases; Esters; Female; Humans; Hydrolysis; Liver; Loperamide; Male; Microsomes, Liver; Molecular Structure; Nitrophenols; Paraoxon; Pentanoic Acids; Phenylacetates; Phenylmethylsulfonyl Fluoride; Procaine; Rats; Rats, Wistar; Skin; Swine; Swine, Miniature; Umbelliferones | 2007 |
Paraoxonase 1 activity in different types of multiple sclerosis.
Topics: Adult; Aryldialkylphosphatase; Cholesterol, LDL; Enzyme Activation; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Male; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Paraoxon; Phenylacetates; Triglycerides | 2009 |
Diet and paraoxonase 1 enzymatic activity in diabetic foot patients from Romania and Belgium: favorable association of high flavonoid dietary intake with arylesterase activity.
Topics: Adult; Aged; Aryldialkylphosphatase; Belgium; Carboxylic Ester Hydrolases; Diabetic Foot; Diet; Diet Records; Female; Flavonoids; Genotype; Humans; Lipids; Male; Middle Aged; Minerals; Paraoxon; Phenylacetates; Romania; Vitamins | 2010 |
Association of midgestation paraoxonase 1 activity and pregnancies complicated by preterm birth.
Topics: Adult; Aryldialkylphosphatase; Case-Control Studies; Female; Gestational Age; Humans; Lipids; Paraoxon; Phenylacetates; Pregnancy; Premature Birth; Retrospective Studies | 2010 |
Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis.
Topics: Adult; Aryldialkylphosphatase; Coronary Artery Disease; Female; Genetic Testing; Genotype; Haplotypes; Humans; India; Male; Middle Aged; Paraoxon; Phenylacetates; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Factors | 2011 |
Paraoxonase 1 (PON1) as a marker of short term death in breast cancer recurrence.
Topics: Adult; Aryldialkylphosphatase; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Enzyme Assays; Female; Humans; Hydrolysis; Logistic Models; Middle Aged; Neoplasm Recurrence, Local; Paraoxon; Phenylacetates; Survival Analysis | 2012 |
Paraoxonase 1 activity in patients with chronic obstructive pulmonary disease.
Topics: Aged; Aryldialkylphosphatase; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Paraoxon; Phenylacetates; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Smoking; Spectrophotometry; Sulfhydryl Compounds; Vital Capacity | 2014 |
Paraoxonase 1 activity in subchronic low-level inorganic arsenic exposure through drinking water.
Topics: Animals; Arsenicals; Aryldialkylphosphatase; Brain Chemistry; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Dose-Response Relationship, Drug; Drinking Water; Insecticides; Male; Microsomes; Microsomes, Liver; Paraoxon; Phenylacetates; Rats; Rats, Wistar; Water Pollutants, Chemical | 2016 |
Modulation of paraoxonase 1 (PON1) activity and protein N-homocysteinylation by bisphosphonates in rats.
Topics: Animals; Aryldialkylphosphatase; Diphosphonates; Homocysteine; Male; Paraoxon; Phenylacetates; Rats, Wistar | 2016 |